The Effect of Foeniculum Vulgare Ironing on Gastrointestinal Recovery After Colorectal Resection
14 septembre 2019 mis à jour par: Ziqiang Wang,MD, West China Hospital
The Effect of Foeniculum Vulgare Ironing on Gastrointestinal Recovery After Colorectal Resection: a Randomized Controlled Trial.
Chinese Medicine Ironing using Foeniculum vulgare has been applied in some departments to promote bowel function recovery, but the efficacy of ironing therapy remains uncertain after colorectal resection surgery.
Aperçu de l'étude
Statut
Complété
Les conditions
Intervention / Traitement
Description détaillée
Postoperative ileus is one of the most common complications after abdominal surgery.
It refers to obstipation and intolerance of oral intake due to nonmechanical factors that disrupt the normal coordinated propulsive motor activity of the gastrointestinal tract following abdominal or nonabdominal surgery.
When the expected period of gastrointestinal recovery time extends beyond what is acceptable, the patient is diagnosed as having a "pathologic" postoperative ileus (POI), which leads to patient discomfort, dissatisfaction, prolonged hospitalization and increased medical expenses.
The incidence of POI is about 17%~24% after abdominal surgery.
Chinese Medicine Ironing using Foeniculum vulgare has been applied in some departments to promote gastrointestinal function recovery as a empiric therapy.
However, the definite efficacy of Foeniculum vulgare ironing therapy（FIT）is uncertain after colorectal resection surgery and whether FIT can reduce the incidence of POI remains unkonown.
Type d'étude
Interventionnel
Inscription (Réel)
300
Phase
- Phase 2
Contacts et emplacements
Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.
Lieux d'étude
-
-
Sichuan
-
Chengdu, Sichuan, Chine, 610041
- Guoxue Road 37#,West China Hospital
-
-
Critères de participation
Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.
Critère d'éligibilité
Âges éligibles pour étudier
18 ans à 85 ans (Adulte, Adulte plus âgé)
Accepte les volontaires sains
Non
Sexes éligibles pour l'étude
Tout
La description
Inclusion Criteria:
- Age: 18 ~ 85 years old; sex is not limited.
- Selective operation of colorectal partial resection.
- Participants are volunteered to participate in this study, sign informed consent, and cooperated with follow-up.
Exclusion Criteria:
- Emergency surgery.
- Pregnant or lactating women.
- ASA class 4 or 5 patients.
- Patients with severe abdominal adhesions, which would cost more than 30 minutes to release. Patients with abdominal cocoon disease.
- Patients with peritoneal metastasis or inflammatory bowel disease.
- Patients undergoing enterostomy or total colectomy.
- Patients simultaneously enrolled in any other competing clinical study.
Plan d'étude
Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: La prévention
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Double
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Aucune intervention: Aucune intervention
Aucune intervention.
|
|
|
Expérimental: Ironing therapy
Stir-fry 500 grams of Foeniculum vulgare seeds until the aroma overflows.
Put them into a cotton bag.
Ironing therapy put the bag on abdomen after the temperature is suitable, 30 minutes per time, 4 times daily from 12 hours after surgery and last for 2 days.
The medicine bag can be heated and reused after it cool down.
|
Stir-fry 500 grams of Foeniculum vulgare seeds until the aroma overflows.
Put them into a cotton bag.
Ironing therapy put the bag on abdomen after the temperature is suitable, 30 minutes per time, twice daily on postoperative days 2 to 3. The medicine bag can be heated and reused after it cool down.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Flatus time
Délai: Up to 30 days after operation.
|
Time to faltus (hours from end of operation).
Patients who had stool before any movement of gas were deemed to have an equal time to the time to flatus and first bowel movement.
|
Up to 30 days after operation.
|
|
Incidence of postoperative ileus
Délai: 4 days after operation
|
The same panel defined "prolonged" postoperative ileus as the occurrence of two or more of the following signs and symptoms on postoperative day 4 or after: Nausea or vomiting, Inability to tolerate an oral diet over the preceding 24 hours, Absence of flatus over the preceding 24 hours, Abdominal distention.
|
4 days after operation
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Toleration of a low-residue diet
Délai: Up to 30 days after operation.
|
Time (hours from end of operation) to tolerate a low-residue diet, defined as consuming >50% of the meal without emesis for 24 hours (time recorded was the time when the patient ate >50% of the meal).
|
Up to 30 days after operation.
|
|
Toleration of drinking water
Délai: Up to 30 days after operation.
|
Time (hours from end of operation) to toleration of water.
|
Up to 30 days after operation.
|
|
Duration of postoperative hospitalization
Délai: Up to 30 days after operation.
|
Postoperative days the patient was ready for hospital discharge based on Gastrointestinal function alone.
|
Up to 30 days after operation.
|
|
Pain assessment
Délai: During postoperative hospitalization, up to 30 days after operation.
|
Assess postoperative pain with the pain visual analogue scale.
Rate the pain levels on a likert scale from 0 (no pain) to 10 (pain as bad as it could possibly be).
|
During postoperative hospitalization, up to 30 days after operation.
|
|
Nausea and appetite assessment
Délai: During postoperative hospitalization, up to 30 days after operation.
|
Rate their appetite and nausea levels on a likert scale from 0 (no appetite, nausea) to 10 (appetite as good as can be, nausea as bad as can be), and each score was recorded separately.
|
During postoperative hospitalization, up to 30 days after operation.
|
|
Short-term complications
Délai: Up to 30 days after operation.
|
Complications during the 30-day postoperative period
|
Up to 30 days after operation.
|
|
Adverse events
Délai: Up to 30 days after operation.
|
Any adverse events possibly related to treatment with Foeniculum vulgare ironing.
|
Up to 30 days after operation.
|
|
Hospitalization costs
Délai: During postoperative hospitalization, up to 30 days after operation.
|
Postoperative in-patients costs
|
During postoperative hospitalization, up to 30 days after operation.
|
Collaborateurs et enquêteurs
C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.
Parrainer
Les enquêteurs
- Chaise d'étude: Ziqiang Wang, MD, West China Hospital
Publications et liens utiles
La personne responsable de la saisie des informations sur l'étude fournit volontairement ces publications. Il peut s'agir de tout ce qui concerne l'étude.
Publications générales
- Choi EM, Hwang JK. Antiinflammatory, analgesic and antioxidant activities of the fruit of Foeniculum vulgare. Fitoterapia. 2004 Sep;75(6):557-65. doi: 10.1016/j.fitote.2004.05.005.
- Iyer S, Saunders WB, Stemkowski S. Economic burden of postoperative ileus associated with colectomy in the United States. J Manag Care Pharm. 2009 Jul-Aug;15(6):485-94. doi: 10.18553/jmcp.2009.15.6.485.
- Ma HW, Zhao JT, Zhao X. [The Effect of Fennel Tea Drinking on Postoperative Gut Recovery after Gynecological Malignancies Operation]. Sichuan Da Xue Xue Bao Yi Xue Ban. 2015 Nov;46(6):940-3. Chinese.
- Miguel MG, Cruz C, Faleiro L, Simoes MT, Figueiredo AC, Barroso JG, Pedro LG. Foeniculum vulgare essential oils: chemical composition, antioxidant and antimicrobial activities. Nat Prod Commun. 2010 Feb;5(2):319-28.
- Rezayat SM, Dehpour AR, Motamed SM, Yazdanparast M, Chamanara M, Sahebgharani M, Rashidian A. Foeniculum vulgare essential oil ameliorates acetic acid-induced colitis in rats through the inhibition of NF-kB pathway. Inflammopharmacology. 2018 Jun;26(3):851-859. doi: 10.1007/s10787-017-0409-1. Epub 2017 Oct 24.
- Jang SH, Yang DK. The combination of Cassia obtusifolia L. and Foeniculum vulgare M. exhibits a laxative effect on loperamide-induced constipation of rats. PLoS One. 2018 Apr 5;13(4):e0195624. doi: 10.1371/journal.pone.0195624. eCollection 2018. Erratum In: PLoS One. 2018 Aug 9;13(8):e0202259.
- Mattei P, Rombeau JL. Review of the pathophysiology and management of postoperative ileus. World J Surg. 2006 Aug;30(8):1382-91. doi: 10.1007/s00268-005-0613-9.
- Bragg D, El-Sharkawy AM, Psaltis E, Maxwell-Armstrong CA, Lobo DN. Postoperative ileus: Recent developments in pathophysiology and management. Clin Nutr. 2015 Jun;34(3):367-76. doi: 10.1016/j.clnu.2015.01.016. Epub 2015 Jan 31.
Dates d'enregistrement des études
Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.
Dates principales de l'étude
Début de l'étude (Réel)
20 octobre 2018
Achèvement primaire (Réel)
15 juin 2019
Achèvement de l'étude (Réel)
15 juillet 2019
Dates d'inscription aux études
Première soumission
12 octobre 2018
Première soumission répondant aux critères de contrôle qualité
17 octobre 2018
Première publication (Réel)
18 octobre 2018
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
17 septembre 2019
Dernière mise à jour soumise répondant aux critères de contrôle qualité
14 septembre 2019
Dernière vérification
1 juillet 2019
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- FV-GIR-2018
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
NON
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Non
Étudie un produit d'appareil réglementé par la FDA américaine
Non
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .